Evidence map›Paper›PMID 42256426›Full record

ArticleInnovations in pharmacy2025

Pharmacist roles across the space mission pathway.

Muhammad Ahmer Raza, Shireen Aziz

Abstract read
In one paragraph

Article in Innovations in pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Muhammad Ahmer RazaIndependent scholar, Pakistan.ORCID https://orcid.org/0000-0003-2906-5783
Shireen AzizIndependent scholar, Czechia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advancement of human space exploration presents unprecedented healthcare challenges, and heightens the need for specialized pharmaceutical care across the distinct timelines of a space mission. Despite growing interest in integrating pharmacists into space healthcare, their roles remain largely generalized, not tailored to the specific demands of pre-mission preparation, in-mission operations, and post-mission recovery. Each phase introduces unique challenges, including microgravity, radiation, and the constraints of long-duration missions, which can compromise drug stability, alter pharmacokinetics, and impact astronaut health. This commentary addresses these gaps, proposing a timeline-based approach to pharmacist involvement in space missions to ensure tailored healthcare delivery at every stage. These approaches will not only enhance astronaut health and mission outcomes but will also contribute to advancing healthcare practices on Earth. Future efforts should focus on operationalizing these frameworks to optimize pharmacotherapy in space exploration.

Indexed as

pharmacistspace missiontimeline of a space mission

Identifiers

PMID42256426
PMCPMC13233165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.